大麻二酚 (CBD) 消費者健康市場：按產品、分銷管道和地區 - 規模、份額、前景、機會分析，2023-2030 年

Cannabidiol (CBD) Consumer Health Market, By Products, By Distribution Channel, By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: 2023年08月08日 | 出版商:

Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2030 年，全球大麻二酚 (CBD) 消費者保健市場價值將達到 820 億美元，2023 年至 2030 年複合年增長率為 23.2%。

報告範圍		報告詳細資料
基準年	2022	2023 年市場規模	190億美元
過去的資料	2018年至2021年	預測期間	2023-2030
預測 2023-2030 年複合年增長率：	23.20%	2030年價值預測	820億美元

大麻二酚(CBD) 是一種常見於大麻和大麻植物中的化合物，這種萃取物已被證明可以治療多種疾病，包括慢性疼痛、神經性疼痛、焦慮、睡眠障礙、噁心和壓力。被發現是有效的。因此，大麻二酚在各地受到廣泛歡迎。這種萃取物約佔整株植物的 40%，已知對人體沒有成癮作用。 CBD 天然存在於大麻植物中。雖然這種油是從大麻中提取的，但它沒有其他大麻產品的有害影響。 CBD油在治療多種健康疾病方面也顯示出積極的效果，包括阿茲海默症、多發性硬化症和帕金森氏症。

市場動態：

注入 CBD 的產品是全球的最新趨勢。人們對 CBD 產品的醫療益處的認識不斷提高，導致越來越多的人不考慮成本地購買這些產品，預計這將在預測期內推動全球大麻二酚 (CBD) 消費者健康市場的發展。生長。

目前，亞太地區有多家營養保健品公司提供各種形式的補充品和功能性食品。例如，澳洲公司MGC Pharma在中國推出了CBD營養補充品產品線，包括CBD膠囊、水溶性CBD溶液和大麻粉。這些產品在短時間內獲得了消費者的廣泛接受，因為它們提供了 CBD 的健康益處，但沒有精神作用。此外，亞太地區各國大麻合法化增加了對大麻衍生 CBD 產品的需求。

本研究的主要特點

本報告詳細分析了全球大麻二酚 (CBD) 消費者健康市場，包括以 2022 年為基準年的預測期（2023-2030 年）的市場規模和復合年增長率 (CAGR%)。）提供。
它也闡明了各個細分市場的潛在收入機會，並概述了該市場有吸引力的投資主張矩陣。
它還提供了有關市場驅動因素、限制因素、機會、新產品發布和批准、市場趨勢、區域前景、主要參與者採取的競爭策略等的重要見解。
根據公司亮點、產品組合、主要亮點、財務表現和策略等參數，介紹全球大麻二酚 (CBD) 消費者健康市場的領先公司。
本研究涵蓋的主要公司包括 CV Sciences, Inc.、Medical Marijuana, Inc.、AXIM-Biotechnologies, Inc.、Charlotte's Web、Endoca、Isodiol International Inc.、Elixinol、Folium Biosciences 和 NuLeaf Naturals, LLC 、 Cannoid 、 LLC 等。
該報告的見解將使行銷人員和公司高層能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
《全球大麻二酚(CBD) 消費者健康市場報告》滿足該行業的各種利益相關者的需求，例如投資者、供應商、產品製造商、分銷商、新進入者和財務分析師。
利害關係人可以透過在分析全球大麻二酚 (CBD) 消費者健康市場時使用的各種策略矩陣來促進決策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023:	US$ 19.0 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	23.20%	2030 Value Projection:	US$ 82.0 Bn

Cannabidiol (CBD) is a compound commonly found in hemp and marijuana plants, this extract is found to be effective against numerous disorders such as chronic pain, neurological pain, anxiety, sleep disorder, as well as nausea and stress. Hence, cannabidiol is gaining widespread popularity across various regions. This extract consists approximately 40% of the entire plant and it is known to not cause any dependence effects on the human body. CBD is found naturally in marijuana plants. Though the oil is derived from marijuana, it does not have any harmful effects like any other product derived from cannabis. CBD oil is also showing positive results in treating various health disorders such as Alzheimer's disease, multiple sclerosis, Parkinson's disease, and others.

Market Dynamics:

CBD-infused products have become the latest trend across the world. Increasing awareness about the medical benefits of CBD-infused products is leading to an increase in the number of people willing to buy these products, irrespective of cost and this is expected to augment the growth of the global cannabidiol (CBD) consumer health market during the forecast period.

In the Asia Pacific region, several nutraceutical companies are now offering a wide variety of supplements and functional foods in various forms. For instance, an Australian company-MGC Pharma-launched its CBD nutraceutical-product line, including CBD capsules, water-soluble CBD solutions, and hemp powder, in China. These products have gained significant acceptance among consumers within a short span, as they offer health benefits of CBD without any psychoactive effects. In addition, the demand for hemp-derived CBD products is increasing due to the legalization of hemp in various countries in the Asia Pacific region.

Key features of the study:

This report provides in-depth analysis of the global cannabidiol (CBD) consumer health market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global cannabidiol (CBD) consumer health market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include CV Sciences, Inc., Medical Marijuana, Inc., AXIM-Biotechnologies, Inc., Charlotte's Web, Endoca, Isodiol International Inc., Elixinol, Folium Biosciences, NuLeaf Naturals, LLC, Cannoid, LLC, among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global cannabidiol (CBD) consumer health market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cannabidiol (CBD) consumer health market.

Detailed Segmentation:

Global Cannabidiol (CBD) Consumer Health Market, By Products:
- Medical OTC Products Targeted Therapy
- Analgesics
- Dermatology
- Mental Health
- Sleeping Aids
- Others
- Nutraceuticals
- CBD Vitamins and Dietary Supplements (VDS)
- CBD Sports Nutrition
- CBD Weight Management and Wellbeing
Global Cannabidiol (CBD) Consumer Health Market, By Distribution Channel:
- Online Stores
- Retail Pharmacies
- Retail Stores
Global Cannabidiol (CBD) Consumer Health Market, By Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Company Profiles:
- CV Sciences, Inc.
- Medical Marijuana, Inc.
- AXIM-Biotechnologies, Inc.
- Charlotte's Web
- Endoca
- Isodiol
- Elixinol
- Folium Biosciences
- Cannoid, LLC

Market Dynamics
- Cannabis revolution positively impacting consumer health market
- Availability of alternatives to CBD supplements
- Uncertain government regulations related to CBD and CBD products
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Cannabidiol (CBD) Consumer Health Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Cannabidiol (CBD) Consumer Health Market, By Products, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Medical OTC Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Analgesics
Dermatology
Mental Health
Sleeping Aids
Others
Nutraceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
CBD Vitamins and Dietary Supplements (VDS)
CBD Sports Nutrition
CBD Weight Management and Wellbeing

6. Global Cannabidiol (CBD) Consumer Health Market, By Distribution Channel, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Online Stores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Retail Stores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

7. Global Cannabidiol (CBD) Consumer Health Market, By Region, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Middle East and Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)

8. Competitive Landscape

CV Sciences, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medical Marijuana, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AXIM-Biotechnologies, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Charlotte's Web
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Endoca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Isodiol
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Elixinol
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Folium Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
NuLeaf Naturals, LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cannoid, LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views